BioAge Stock

bioagelabs.comHealthcareFounded: 2015Funding to Date: $132.86MM

BioAge develops a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging by using its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking individuals over the lifespan, to map out the key molecular pathways that impact healthy human aging.

Register for Details

For more details on financing and valuation for BioAge, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for BioAge.

Register Today

Other companies like BioAge in the Healthcare sector

Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.33B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$67.5MM
Sector
Last Round Est. Valuation
$1.19B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$8.18B